Literature DB >> 11461749

Clinical determinants of increased QT dispersion in patients with diabetes mellitus.

C Cardoso1, G Salles, K Bloch, W Deccache, A G Siqueira-Filho.   

Abstract

AIMS: To compare QT dispersion measurements in diabetic patients to control subjects and assess any associations between QT dispersion and diabetic clinical characteristics.
METHODS: A total of 512 diabetics and 50 age and gender matched controls were studied. QT interval was measured manually in 12-lead conventional electrocardiograms, and QT dispersion (QTd), heart rate-corrected QT dispersion (QTcd), number of leads-adjusted QT dispersion (adjuQTd) and adjacent QT dispersion (adjaQTd) were calculated. Demographic, clinical, laboratory and electrocardiographic data were recorded.
RESULTS: Diabetics showed increased QT dispersion compared to controls (QTd: P<0.001, QTcd: P<0.001, adjuQTd: P<0.001), even those with recent diagnosis (less than 2 years) and without arterial hypertension, ECG abnormalities or chronic degenerative complications (QTd: P=0.01, QTcd: P<0.001, adjuQTd: P=0.04). Left ventricular hypertrophy (QTd: P<0.001, QTcd: P<0.001, adjuQTd: P<0.001, adjaQTd: P<0.001) and conduction disturbances (QTd: P=0.002, QTcd: P=0.003, adjuQTd: P=0.003) were the electrocardiographic findings associated with increased QT dispersion in bivariate analysis. Clinical variables were the presence of arterial hypertension (QTd: P=0.004, QTcd: P=0.01, adjuQTd: P<0.001), even without left ventricular hypertrophy (QTd: P=0.01, QTcd: P=0.03, adjuQTd: P=0.003), and the presence of diabetic cardiovascular complications (QTd: P=0.02, QTcd: P=0.01, adjuQTd: P=0.008, adjaQTd: P=0.03). No association between QT dispersion and the presence of diabetic microvascular complications, glycaemic control, age and gender, or cardiovascular drugs was observed. Multivariate regressive statistical analysis confirmed the associations noted in bivariate analysis.
CONCLUSIONS: Diabetic patients have increased QT dispersion compared to non-diabetics even those without arterial hypertension and cardiovascular complications and with recent diagnosis. The presence of arterial hypertension, diabetic cardiovascular complications and electrocardiographic abnormalities of left ventricular hypertrophy and conduction disturbances were associated to increased QT dispersion in diabetes mellitus.

Entities:  

Mesh:

Year:  2001        PMID: 11461749     DOI: 10.1016/s0167-5273(01)00443-0

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Marked exercise-induced T-wave heterogeneity in symptomatic diabetic patients with nonflow-limiting coronary artery stenosis.

Authors:  Fernando G Stocco; Ederson Evaristo; Nishant R Shah; Michael K Cheezum; Jon Hainer; Courtney Foster; Bruce D Nearing; Ernest Gervino; Richard L Verrier
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-09-26       Impact factor: 1.468

2.  Increased serum gamma-glutamyltransferase levels are associated with ventricular instability in type 2 diabetes.

Authors:  Kun Wang; Ling Li; Yang Wu; Yu Yang; Jie Chen; Danyu Zhang; Zhoujun Liu; Juan Xu; Meng Cao; Xiaodong Mao; Chao Liu
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

3.  Reduced functional connectivity between ventromedial prefrontal cortex and insula relates to longer corrected QT interval in HIV+ and HIV- individuals.

Authors:  Roger C McIntosh; Dominic C Chow; Corey J Lum; Melissa Hidalgo; Cecilia M Shikuma; Kalpana J Kallianpur
Journal:  Clin Neurophysiol       Date:  2017-07-25       Impact factor: 3.708

4.  Ranolazine reduces repolarization heterogeneity in symptomatic patients with diabetes and non-flow-limiting coronary artery stenosis.

Authors:  Ederson Evaristo; Fernando G Stocco; Nishant R Shah; Michael K Cheezum; Jon Hainer; Courtney Foster; Bruce D Nearing; Marcelo Di Carli; Richard L Verrier
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-06-27       Impact factor: 1.468

5.  Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes.

Authors:  Vladan M Ninkovic; Srdjan M Ninkovic; Vanja Miloradovic; Dejan Stanojevic; Marijana Babic; Vojislav Giga; Milan Dobric; Michael I Trenell; Nebojsa Lalic; Petar M Seferovic; Djordje G Jakovljevic
Journal:  Acta Diabetol       Date:  2016-04-23       Impact factor: 4.280

Review 6.  QT interval, cardiovascular risk factors and risk of death in diabetes.

Authors:  M Veglio; A Chinaglia; P Cavallo-Perin
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

7.  The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes.

Authors:  Jian-Bin Su; Xiao-Hua Yang; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Li-Hua Zhao; Feng Xu; Tong Chen; Xing-Bo Cheng; Xue-Qin Wang; Yan Lu
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

8.  The relationship between insulin sensitivity and heart rate-corrected QT interval in patients with type 2 diabetes.

Authors:  Xiao-Hua Yang; Jian-Bin Su; Xiu-Lin Zhang; Li-Hua Zhao; Feng Xu; Xue-Qin Wang; Xing-Bo Cheng
Journal:  Diabetol Metab Syndr       Date:  2017-09-11       Impact factor: 3.320

Review 9.  Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes.

Authors:  Mónica Gallego; Julián Zayas-Arrabal; Amaia Alquiza; Beatriz Apellaniz; Oscar Casis
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

Review 10.  miRNAs at the heart of the matter.

Authors:  Zhiguo Wang; Xioabin Luo; Yanjie Lu; Baofeng Yang
Journal:  J Mol Med (Berl)       Date:  2008-04-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.